 Irina Petrache
Concepts (584)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 34 | 2023 | 280 | 9.530 |
Why?
| | Ceramides | 23 | 2023 | 94 | 5.440 |
Why?
| | alpha 1-Antitrypsin | 15 | 2023 | 107 | 5.340 |
Why?
| | Lung | 53 | 2023 | 3595 | 4.760 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 23 | 2023 | 928 | 4.530 |
Why?
| | Endothelial Cells | 24 | 2023 | 685 | 4.380 |
Why?
| | Smoking | 30 | 2020 | 1392 | 4.250 |
Why?
| | Apoptosis | 38 | 2020 | 2366 | 3.700 |
Why?
| | Cigarette Smoking | 8 | 2022 | 74 | 3.660 |
Why?
| | Lung Injury | 11 | 2023 | 198 | 3.620 |
Why?
| | Smoke | 12 | 2021 | 127 | 3.250 |
Why?
| | Electronic Nicotine Delivery Systems | 7 | 2023 | 72 | 3.100 |
Why?
| | Emphysema | 10 | 2023 | 110 | 2.570 |
Why?
| | Sphingolipids | 7 | 2018 | 58 | 2.360 |
Why?
| | alpha 1-Antitrypsin Deficiency | 8 | 2019 | 76 | 2.260 |
Why?
| | Pulmonary Alveoli | 15 | 2018 | 374 | 2.240 |
Why?
| | Macrophages, Alveolar | 5 | 2021 | 351 | 2.210 |
Why?
| | Vaping | 3 | 2023 | 45 | 1.690 |
Why?
| | Sphingomyelin Phosphodiesterase | 6 | 2023 | 22 | 1.580 |
Why?
| | Animals | 86 | 2023 | 31867 | 1.500 |
Why?
| | Endothelium, Vascular | 11 | 2023 | 850 | 1.490 |
Why?
| | Tobacco Products | 5 | 2021 | 101 | 1.470 |
Why?
| | Microvessels | 4 | 2021 | 68 | 1.440 |
Why?
| | Mice | 56 | 2023 | 14927 | 1.430 |
Why?
| | Hypertension, Pulmonary | 8 | 2022 | 1736 | 1.370 |
Why?
| | Signal Transduction | 19 | 2020 | 4525 | 1.360 |
Why?
| | Oxidative Stress | 13 | 2020 | 1085 | 1.330 |
Why?
| | Cells, Cultured | 23 | 2021 | 3896 | 1.260 |
Why?
| | Autophagy | 7 | 2021 | 234 | 1.260 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2017 | 1138 | 1.220 |
Why?
| | Disease Models, Animal | 16 | 2022 | 3545 | 1.210 |
Why?
| | Mice, Inbred C57BL | 27 | 2022 | 4718 | 1.200 |
Why?
| | Alveolar Epithelial Cells | 3 | 2018 | 96 | 1.190 |
Why?
| | Acute Lung Injury | 3 | 2021 | 300 | 1.190 |
Why?
| | Pneumonia | 5 | 2021 | 568 | 1.110 |
Why?
| | Hypoxia | 6 | 2020 | 958 | 1.060 |
Why?
| | Receptors, Estrogen | 3 | 2014 | 372 | 1.050 |
Why?
| | Caspase 3 | 7 | 2016 | 237 | 1.050 |
Why?
| | Pulmonary Artery | 10 | 2022 | 1028 | 1.040 |
Why?
| | Membrane Proteins | 5 | 2022 | 1019 | 1.040 |
Why?
| | Adipose Tissue | 5 | 2017 | 558 | 1.000 |
Why?
| | MicroRNAs | 2 | 2022 | 603 | 1.000 |
Why?
| | Humans | 98 | 2024 | 115042 | 0.980 |
Why?
| | Rats | 22 | 2017 | 4973 | 0.970 |
Why?
| | Tobacco Smoke Pollution | 4 | 2018 | 217 | 0.940 |
Why?
| | Neovascularization, Physiologic | 3 | 2020 | 173 | 0.930 |
Why?
| | Up-Regulation | 10 | 2020 | 812 | 0.930 |
Why?
| | Endothelium | 4 | 2023 | 112 | 0.930 |
Why?
| | Endocytosis | 3 | 2016 | 151 | 0.920 |
Why?
| | Vascular System Injuries | 1 | 2023 | 64 | 0.810 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 5 | 0.760 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 5 | 0.760 |
Why?
| | Phagocytosis | 3 | 2021 | 352 | 0.760 |
Why?
| | Rats, Sprague-Dawley | 14 | 2018 | 2212 | 0.760 |
Why?
| | Lysophospholipase | 1 | 2021 | 11 | 0.760 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2020 | 15 | 0.700 |
Why?
| | Translocation, Genetic | 1 | 2020 | 94 | 0.700 |
Why?
| | Hyaluronic Acid | 2 | 2020 | 189 | 0.690 |
Why?
| | Immunoglobulins | 1 | 2020 | 143 | 0.690 |
Why?
| | Glucosylceramides | 1 | 2019 | 7 | 0.690 |
Why?
| | Macrophages | 4 | 2021 | 1267 | 0.680 |
Why?
| | Epithelial Cells | 10 | 2022 | 956 | 0.680 |
Why?
| | Mice, Knockout | 11 | 2021 | 2585 | 0.680 |
Why?
| | Estradiol | 3 | 2018 | 455 | 0.680 |
Why?
| | Glycoproteins | 1 | 2021 | 305 | 0.660 |
Why?
| | Enzyme Inhibitors | 4 | 2018 | 752 | 0.650 |
Why?
| | Influenza, Human | 2 | 2022 | 546 | 0.650 |
Why?
| | Antibodies, Neutralizing | 2 | 2019 | 221 | 0.640 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2019 | 26 | 0.640 |
Why?
| | Lysosomes | 2 | 2021 | 123 | 0.620 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.620 |
Why?
| | Heterocyclic Compounds | 1 | 2018 | 18 | 0.610 |
Why?
| | Sphingosine | 5 | 2015 | 33 | 0.610 |
Why?
| | Neoplasm Proteins | 5 | 2019 | 385 | 0.610 |
Why?
| | RNA-Binding Proteins | 5 | 2019 | 352 | 0.610 |
Why?
| | Xeroderma Pigmentosum | 1 | 2018 | 7 | 0.610 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2018 | 590 | 0.600 |
Why?
| | Metformin | 1 | 2021 | 278 | 0.600 |
Why?
| | Oncostatin M | 1 | 2017 | 5 | 0.600 |
Why?
| | Sphingosine N-Acyltransferase | 2 | 2018 | 4 | 0.590 |
Why?
| | Thorax | 2 | 2022 | 41 | 0.580 |
Why?
| | Cell Movement | 4 | 2020 | 866 | 0.560 |
Why?
| | Cell Death | 4 | 2019 | 324 | 0.550 |
Why?
| | Multiprotein Complexes | 1 | 2018 | 141 | 0.550 |
Why?
| | DNA Repair | 1 | 2018 | 186 | 0.540 |
Why?
| | Male | 43 | 2022 | 55731 | 0.540 |
Why?
| | Genetic Predisposition to Disease | 3 | 2020 | 2108 | 0.520 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 58 | 0.510 |
Why?
| | DNA Damage | 1 | 2018 | 357 | 0.510 |
Why?
| | Scavenger Receptors, Class B | 1 | 2015 | 9 | 0.510 |
Why?
| | Cytokines | 9 | 2019 | 1843 | 0.500 |
Why?
| | Telemetry | 1 | 2015 | 35 | 0.500 |
Why?
| | Cosmic Radiation | 1 | 2014 | 5 | 0.490 |
Why?
| | Mice, Transgenic | 8 | 2022 | 1955 | 0.490 |
Why?
| | ADAM Proteins | 3 | 2022 | 58 | 0.490 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 61 | 0.480 |
Why?
| | Female | 34 | 2022 | 59613 | 0.480 |
Why?
| | Oxidoreductases | 4 | 2011 | 92 | 0.470 |
Why?
| | Transcytosis | 1 | 2014 | 9 | 0.470 |
Why?
| | Cell Proliferation | 9 | 2020 | 2191 | 0.470 |
Why?
| | Alginates | 1 | 2014 | 44 | 0.470 |
Why?
| | Palmitic Acids | 1 | 2014 | 9 | 0.460 |
Why?
| | Receptors, Lysosphingolipid | 2 | 2014 | 12 | 0.460 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2013 | 271 | 0.460 |
Why?
| | Lung Diseases | 3 | 2017 | 703 | 0.460 |
Why?
| | Thoracic Vertebrae | 1 | 2014 | 72 | 0.460 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 100 | 0.460 |
Why?
| | Caspase Inhibitors | 3 | 2011 | 78 | 0.450 |
Why?
| | Inflammation | 7 | 2023 | 2485 | 0.450 |
Why?
| | Spinal Injuries | 1 | 2014 | 48 | 0.450 |
Why?
| | Stem Cell Transplantation | 2 | 2015 | 149 | 0.450 |
Why?
| | Enzyme Activation | 8 | 2015 | 791 | 0.440 |
Why?
| | Tracheostomy | 1 | 2014 | 100 | 0.430 |
Why?
| | Interleukin-6 | 1 | 2016 | 676 | 0.420 |
Why?
| | Trypsin Inhibitors | 2 | 2017 | 6 | 0.420 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 186 | 0.420 |
Why?
| | Nicotine | 1 | 2015 | 266 | 0.420 |
Why?
| | Lysophospholipids | 5 | 2015 | 65 | 0.420 |
Why?
| | Cystic Fibrosis | 2 | 2014 | 957 | 0.410 |
Why?
| | Metabolomics | 5 | 2018 | 527 | 0.400 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 299 | 0.400 |
Why?
| | Exercise Therapy | 1 | 2015 | 351 | 0.390 |
Why?
| | Estrogens | 1 | 2014 | 313 | 0.380 |
Why?
| | Cell Differentiation | 2 | 2018 | 1700 | 0.380 |
Why?
| | Photons | 1 | 2011 | 56 | 0.370 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 282 | 0.370 |
Why?
| | Stress, Physiological | 1 | 2014 | 377 | 0.370 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 53 | 0.370 |
Why?
| | Virus Diseases | 2 | 2023 | 196 | 0.360 |
Why?
| | Hemodynamics | 1 | 2015 | 1017 | 0.360 |
Why?
| | Adult Stem Cells | 1 | 2010 | 32 | 0.350 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2014 | 1857 | 0.350 |
Why?
| | Pancreatic Elastase | 2 | 2021 | 67 | 0.340 |
Why?
| | Caspases | 3 | 2011 | 245 | 0.340 |
Why?
| | Phenotype | 7 | 2020 | 2815 | 0.330 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2021 | 358 | 0.320 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 305 | 0.320 |
Why?
| | Fingolimod Hydrochloride | 3 | 2022 | 30 | 0.310 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 290 | 0.310 |
Why?
| | Biomarkers | 8 | 2021 | 3419 | 0.290 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1318 | 0.290 |
Why?
| | Mass Spectrometry | 4 | 2018 | 634 | 0.290 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 512 | 0.290 |
Why?
| | Transcription Factors | 2 | 2012 | 1531 | 0.290 |
Why?
| | Heart | 1 | 2011 | 610 | 0.290 |
Why?
| | Fibrinolysin | 1 | 2007 | 15 | 0.290 |
Why?
| | Lipopolysaccharides | 4 | 2023 | 817 | 0.280 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2016 | 141 | 0.280 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 541 | 0.270 |
Why?
| | Thrombin | 1 | 2007 | 141 | 0.270 |
Why?
| | Electric Impedance | 3 | 2015 | 98 | 0.270 |
Why?
| | Vascular Remodeling | 3 | 2022 | 153 | 0.260 |
Why?
| | Gene Expression Regulation | 5 | 2020 | 2329 | 0.260 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 4 | 2012 | 103 | 0.260 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 287 | 0.260 |
Why?
| | ADAM17 Protein | 2 | 2017 | 31 | 0.250 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 173 | 0.250 |
Why?
| | Leukocytes | 3 | 2022 | 277 | 0.250 |
Why?
| | Cell Adhesion | 2 | 2020 | 430 | 0.240 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2341 | 0.240 |
Why?
| | Caspase 6 | 2 | 2016 | 5 | 0.240 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2015 | 125 | 0.240 |
Why?
| | Caspase 7 | 2 | 2016 | 22 | 0.240 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 616 | 0.230 |
Why?
| | Middle Aged | 11 | 2022 | 26827 | 0.230 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 21 | 0.220 |
Why?
| | Homeostasis | 3 | 2018 | 578 | 0.220 |
Why?
| | Capillary Permeability | 2 | 2015 | 135 | 0.220 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 344 | 0.220 |
Why?
| | Receptors, CXCR3 | 2 | 2013 | 15 | 0.220 |
Why?
| | Biomedical Technology | 1 | 2024 | 40 | 0.220 |
Why?
| | Monocytes | 4 | 2023 | 503 | 0.220 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2003 | 19 | 0.220 |
Why?
| | rho GTP-Binding Proteins | 1 | 2003 | 61 | 0.210 |
Why?
| | Cell Line | 4 | 2017 | 2645 | 0.210 |
Why?
| | Pulmonary Medicine | 1 | 2024 | 87 | 0.210 |
Why?
| | Oxygen Consumption | 2 | 2022 | 588 | 0.210 |
Why?
| | Cell Adhesion Molecules | 2 | 2015 | 168 | 0.200 |
Why?
| | X-Ray Microtomography | 2 | 2022 | 74 | 0.200 |
Why?
| | Primary Cell Culture | 2 | 2013 | 149 | 0.200 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1153 | 0.200 |
Why?
| | Dronabinol | 1 | 2023 | 118 | 0.200 |
Why?
| | Flow Cytometry | 4 | 2015 | 1084 | 0.200 |
Why?
| | Influenza A virus | 1 | 2022 | 90 | 0.200 |
Why?
| | Congresses as Topic | 1 | 2023 | 198 | 0.190 |
Why?
| | Societies, Medical | 2 | 2023 | 678 | 0.190 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 10 | 0.190 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 10 | 0.190 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.190 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2021 | 35 | 0.190 |
Why?
| | CD11 Antigens | 1 | 2021 | 31 | 0.190 |
Why?
| | Cell Size | 1 | 2021 | 81 | 0.190 |
Why?
| | Lectins | 1 | 2021 | 44 | 0.190 |
Why?
| | Cytoskeleton | 3 | 2011 | 177 | 0.190 |
Why?
| | CD11b Antigen | 1 | 2021 | 58 | 0.190 |
Why?
| | Kinetics | 3 | 2015 | 1558 | 0.190 |
Why?
| | Microtubules | 1 | 2003 | 237 | 0.180 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2020 | 6 | 0.180 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 249 | 0.180 |
Why?
| | Inhalation Exposure | 1 | 2021 | 97 | 0.180 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2020 | 27 | 0.180 |
Why?
| | Endothelial Progenitor Cells | 1 | 2020 | 18 | 0.180 |
Why?
| | Integrin beta1 | 1 | 2020 | 16 | 0.180 |
Why?
| | Sirolimus | 1 | 2021 | 181 | 0.180 |
Why?
| | Blotting, Western | 4 | 2011 | 1149 | 0.180 |
Why?
| | Stem Cell Niche | 1 | 2020 | 42 | 0.180 |
Why?
| | Receptors, CXCR4 | 2 | 2018 | 78 | 0.180 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 67 | 0.180 |
Why?
| | Lactic Acid | 1 | 2022 | 278 | 0.170 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 61 | 0.170 |
Why?
| | Tobacco Smoking | 1 | 2020 | 21 | 0.170 |
Why?
| | Stromal Cells | 2 | 2017 | 96 | 0.170 |
Why?
| | Ischemia | 2 | 2018 | 363 | 0.170 |
Why?
| | Biological Assay | 2 | 2021 | 113 | 0.170 |
Why?
| | Oxidants | 2 | 2011 | 112 | 0.170 |
Why?
| | Case-Control Studies | 2 | 2017 | 3015 | 0.170 |
Why?
| | Cell Membrane | 3 | 2013 | 681 | 0.170 |
Why?
| | Hot Temperature | 1 | 2021 | 304 | 0.170 |
Why?
| | Collagen Type V | 2 | 2009 | 3 | 0.170 |
Why?
| | Exercise Test | 1 | 2022 | 545 | 0.170 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2020 | 139 | 0.160 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 147 | 0.160 |
Why?
| | Eosinophils | 1 | 2021 | 281 | 0.160 |
Why?
| | Adult | 10 | 2022 | 30656 | 0.160 |
Why?
| | Fatty Acids | 1 | 2022 | 385 | 0.160 |
Why?
| | Mannose-Binding Protein-Associated Serine Proteases | 1 | 2019 | 22 | 0.160 |
Why?
| | Serine C-Palmitoyltransferase | 3 | 2008 | 7 | 0.160 |
Why?
| | Paclitaxel | 2 | 2014 | 190 | 0.160 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 349 | 0.160 |
Why?
| | beta Catenin | 1 | 2020 | 220 | 0.160 |
Why?
| | Oxygen | 2 | 2014 | 854 | 0.160 |
Why?
| | Cell Survival | 3 | 2018 | 1022 | 0.160 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2013 | 139 | 0.160 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2014 | 181 | 0.160 |
Why?
| | Databases, Chemical | 1 | 2018 | 6 | 0.150 |
Why?
| | Benzylamines | 1 | 2018 | 39 | 0.150 |
Why?
| | Parenchymal Tissue | 1 | 2018 | 6 | 0.150 |
Why?
| | Imipramine | 1 | 2018 | 12 | 0.150 |
Why?
| | Estrogen Receptor beta | 1 | 2018 | 35 | 0.150 |
Why?
| | Morphine | 2 | 2009 | 122 | 0.150 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 42 | 0.150 |
Why?
| | Chemokine CXCL12 | 1 | 2018 | 74 | 0.150 |
Why?
| | Academic Medical Centers | 1 | 2020 | 412 | 0.150 |
Why?
| | Disease Outbreaks | 1 | 2020 | 309 | 0.150 |
Why?
| | Gene Expression | 2 | 2021 | 1423 | 0.150 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 133 | 0.150 |
Why?
| | Transcriptome | 3 | 2018 | 725 | 0.150 |
Why?
| | Carbon Monoxide | 1 | 2018 | 65 | 0.150 |
Why?
| | Cell Hypoxia | 4 | 2020 | 220 | 0.150 |
Why?
| | Neovascularization, Pathologic | 2 | 2012 | 281 | 0.140 |
Why?
| | Leukocyte Elastase | 1 | 2017 | 79 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 499 | 0.140 |
Why?
| | Bone Marrow | 1 | 2018 | 247 | 0.140 |
Why?
| | Lung Transplantation | 2 | 2009 | 246 | 0.140 |
Why?
| | Protein Binding | 3 | 2018 | 1898 | 0.140 |
Why?
| | THP-1 Cells | 1 | 2016 | 20 | 0.140 |
Why?
| | High-Intensity Interval Training | 1 | 2016 | 18 | 0.140 |
Why?
| | Time Factors | 3 | 2018 | 6141 | 0.140 |
Why?
| | Spinal Cord | 2 | 2009 | 348 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2011 | 278 | 0.140 |
Why?
| | Adipocytes | 1 | 2018 | 189 | 0.140 |
Why?
| | Sleep Apnea Syndromes | 1 | 2017 | 74 | 0.140 |
Why?
| | Pandemics | 2 | 2021 | 1321 | 0.130 |
Why?
| | Bronchi | 1 | 2017 | 243 | 0.130 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 318 | 0.130 |
Why?
| | Aging | 2 | 2021 | 1624 | 0.130 |
Why?
| | Protein Kinases | 1 | 2018 | 307 | 0.130 |
Why?
| | Neutrophils | 1 | 2021 | 1164 | 0.130 |
Why?
| | Delivery of Health Care | 1 | 2022 | 835 | 0.130 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2015 | 37 | 0.130 |
Why?
| | Plasma | 1 | 2017 | 210 | 0.130 |
Why?
| | Monocrotaline | 1 | 2015 | 33 | 0.130 |
Why?
| | I-kappa B Proteins | 2 | 2013 | 78 | 0.130 |
Why?
| | Actins | 3 | 2018 | 383 | 0.130 |
Why?
| | Mice, 129 Strain | 2 | 2012 | 76 | 0.130 |
Why?
| | Ventricular Pressure | 1 | 2015 | 37 | 0.130 |
Why?
| | Myelopoiesis | 1 | 2015 | 6 | 0.120 |
Why?
| | Glycosphingolipids | 1 | 2015 | 8 | 0.120 |
Why?
| | Binding, Competitive | 1 | 2015 | 195 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 344 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2551 | 0.120 |
Why?
| | Cathepsin E | 1 | 2014 | 1 | 0.120 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 138 | 0.120 |
Why?
| | Culture Media, Conditioned | 1 | 2015 | 105 | 0.120 |
Why?
| | Cell Membrane Permeability | 1 | 2015 | 83 | 0.120 |
Why?
| | Collagen Type VI | 1 | 2014 | 4 | 0.120 |
Why?
| | Arterial Pressure | 1 | 2015 | 99 | 0.120 |
Why?
| | Hexuronic Acids | 1 | 2014 | 24 | 0.120 |
Why?
| | Immunoblotting | 1 | 2015 | 282 | 0.120 |
Why?
| | Glucuronic Acid | 1 | 2014 | 27 | 0.120 |
Why?
| | Polysaccharide-Lyases | 1 | 2014 | 12 | 0.120 |
Why?
| | Mitochondrial Dynamics | 1 | 2014 | 23 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2010 | 386 | 0.120 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2015 | 184 | 0.120 |
Why?
| | Asthma | 2 | 2020 | 2051 | 0.120 |
Why?
| | Mice, Inbred C3H | 1 | 2014 | 242 | 0.120 |
Why?
| | United States | 4 | 2024 | 12226 | 0.120 |
Why?
| | Metabolome | 1 | 2017 | 285 | 0.120 |
Why?
| | Propylene Glycols | 2 | 2014 | 25 | 0.120 |
Why?
| | HIV Infections | 3 | 2017 | 2470 | 0.120 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2014 | 55 | 0.110 |
Why?
| | Glycolysis | 1 | 2015 | 227 | 0.110 |
Why?
| | Dehydroepiandrosterone | 1 | 2014 | 49 | 0.110 |
Why?
| | Ligands | 3 | 2023 | 565 | 0.110 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2016 | 218 | 0.110 |
Why?
| | Hyperoxia | 1 | 2015 | 99 | 0.110 |
Why?
| | Ventricular Remodeling | 2 | 2015 | 227 | 0.110 |
Why?
| | HMGB1 Protein | 1 | 2014 | 48 | 0.110 |
Why?
| | Paracrine Communication | 1 | 2014 | 56 | 0.110 |
Why?
| | Oligopeptides | 2 | 2014 | 234 | 0.110 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2013 | 56 | 0.110 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2013 | 52 | 0.110 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 190 | 0.110 |
Why?
| | Virulence | 1 | 2014 | 228 | 0.110 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 1812 | 0.110 |
Why?
| | Smoking Cessation | 1 | 2017 | 376 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2014 | 172 | 0.110 |
Why?
| | Calpain | 1 | 2013 | 53 | 0.110 |
Why?
| | Glycerylphosphorylcholine | 1 | 2013 | 5 | 0.110 |
Why?
| | Ventricular Function, Right | 1 | 2015 | 252 | 0.110 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 276 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4411 | 0.110 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2006 | 499 | 0.110 |
Why?
| | Bronchitis, Chronic | 1 | 2013 | 17 | 0.110 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2013 | 38 | 0.110 |
Why?
| | Dermatitis, Contact | 1 | 2013 | 23 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1901 | 0.110 |
Why?
| | Cattle | 3 | 2008 | 924 | 0.110 |
Why?
| | Platelet Activating Factor | 1 | 2013 | 87 | 0.110 |
Why?
| | Liposomes | 1 | 2014 | 146 | 0.110 |
Why?
| | Proteolysis | 1 | 2013 | 143 | 0.100 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2013 | 45 | 0.100 |
Why?
| | Neuralgia | 1 | 2014 | 122 | 0.100 |
Why?
| | Lung Compliance | 1 | 2012 | 49 | 0.100 |
Why?
| | Risk Factors | 4 | 2020 | 8642 | 0.100 |
Why?
| | Drug Tolerance | 2 | 2009 | 79 | 0.100 |
Why?
| | Estrogen Antagonists | 1 | 2012 | 39 | 0.100 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 69 | 0.100 |
Why?
| | Airway Remodeling | 1 | 2012 | 57 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 400 | 0.100 |
Why?
| | Analgesics, Opioid | 2 | 2009 | 774 | 0.100 |
Why?
| | Cardiac Output | 1 | 2012 | 143 | 0.100 |
Why?
| | Aged | 5 | 2020 | 19119 | 0.100 |
Why?
| | Atmosphere Exposure Chambers | 1 | 2011 | 6 | 0.100 |
Why?
| | Exercise | 1 | 2022 | 1644 | 0.100 |
Why?
| | Polymerase Chain Reaction | 2 | 2015 | 999 | 0.100 |
Why?
| | Catalase | 1 | 2011 | 117 | 0.100 |
Why?
| | Bronchioles | 1 | 2011 | 22 | 0.100 |
Why?
| | Analysis of Variance | 1 | 2014 | 1229 | 0.090 |
Why?
| | Goblet Cells | 1 | 2011 | 16 | 0.090 |
Why?
| | Microcirculation | 1 | 2011 | 135 | 0.090 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2011 | 153 | 0.090 |
Why?
| | Permeability | 1 | 2011 | 148 | 0.090 |
Why?
| | Immunization, Passive | 1 | 2011 | 73 | 0.090 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 192 | 0.090 |
Why?
| | Inflammasomes | 1 | 2012 | 115 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2013 | 370 | 0.090 |
Why?
| | Ceramidases | 1 | 2010 | 4 | 0.090 |
Why?
| | Phosphorylation | 1 | 2015 | 1572 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 343 | 0.090 |
Why?
| | Plant Extracts | 1 | 2012 | 154 | 0.090 |
Why?
| | Perfusion | 1 | 2011 | 151 | 0.090 |
Why?
| | Carcinogens | 1 | 2011 | 105 | 0.090 |
Why?
| | Jurkat Cells | 1 | 2010 | 127 | 0.090 |
Why?
| | Acetylcysteine | 1 | 2011 | 142 | 0.090 |
Why?
| | Stem Cells | 1 | 2015 | 546 | 0.090 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 398 | 0.090 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2010 | 56 | 0.090 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 481 | 0.090 |
Why?
| | Biosensing Techniques | 1 | 2011 | 99 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2017 | 2563 | 0.090 |
Why?
| | Transplantation, Heterologous | 1 | 2010 | 182 | 0.090 |
Why?
| | Myocardium | 1 | 2015 | 922 | 0.090 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 41 | 0.090 |
Why?
| | Mutation | 1 | 2020 | 3350 | 0.090 |
Why?
| | Oxidation-Reduction | 3 | 2022 | 926 | 0.090 |
Why?
| | Cell Line, Tumor | 3 | 2011 | 2715 | 0.090 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 370 | 0.090 |
Why?
| | Posterior Horn Cells | 1 | 2009 | 4 | 0.080 |
Why?
| | Immunosuppressive Agents | 2 | 2014 | 651 | 0.080 |
Why?
| | Software | 1 | 2013 | 537 | 0.080 |
Why?
| | Pulmonary Circulation | 1 | 2011 | 407 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1634 | 0.080 |
Why?
| | Transplantation Tolerance | 1 | 2009 | 31 | 0.080 |
Why?
| | Clathrin | 1 | 2009 | 27 | 0.080 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 84 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2013 | 668 | 0.080 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1317 | 0.080 |
Why?
| | Heart Ventricles | 1 | 2014 | 714 | 0.080 |
Why?
| | Transplantation, Homologous | 1 | 2010 | 390 | 0.080 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2006 | 71 | 0.080 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 11 | 0.080 |
Why?
| | Sex Factors | 1 | 2014 | 1721 | 0.080 |
Why?
| | Protein Precursors | 1 | 2009 | 119 | 0.080 |
Why?
| | Cyclosporine | 1 | 2009 | 161 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2014 | 723 | 0.080 |
Why?
| | Histocompatibility Antigens | 1 | 2009 | 100 | 0.080 |
Why?
| | Pyrroles | 1 | 2009 | 181 | 0.080 |
Why?
| | Obesity | 2 | 2020 | 2524 | 0.080 |
Why?
| | Superoxide Dismutase-1 | 1 | 2008 | 8 | 0.080 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2008 | 34 | 0.080 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2020 | 236 | 0.080 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 262 | 0.080 |
Why?
| | Glycerophospholipids | 2 | 2018 | 26 | 0.080 |
Why?
| | Patch-Clamp Techniques | 1 | 2009 | 241 | 0.080 |
Why?
| | Transglutaminases | 1 | 2008 | 142 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2009 | 353 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2020 | 2098 | 0.070 |
Why?
| | Caspase 9 | 2 | 2008 | 48 | 0.070 |
Why?
| | Indoles | 1 | 2009 | 304 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 256 | 0.070 |
Why?
| | Superoxides | 1 | 2008 | 214 | 0.070 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 287 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 267 | 0.070 |
Why?
| | Antiviral Agents | 2 | 2023 | 647 | 0.070 |
Why?
| | Organ Size | 1 | 2008 | 444 | 0.070 |
Why?
| | Cisplatin | 1 | 2008 | 262 | 0.070 |
Why?
| | Cell-Free System | 1 | 2006 | 47 | 0.070 |
Why?
| | Capillaries | 1 | 2006 | 91 | 0.070 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 963 | 0.070 |
Why?
| | Antigens, CD | 2 | 2011 | 441 | 0.070 |
Why?
| | Graft Rejection | 1 | 2009 | 522 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1477 | 0.070 |
Why?
| | Weight Loss | 1 | 2010 | 641 | 0.060 |
Why?
| | Blood Pressure | 1 | 2012 | 1539 | 0.060 |
Why?
| | Fumonisins | 1 | 2005 | 3 | 0.060 |
Why?
| | Disease Progression | 1 | 2012 | 2389 | 0.060 |
Why?
| | Adenoviridae | 1 | 2006 | 184 | 0.060 |
Why?
| | Acyltransferases | 1 | 2005 | 46 | 0.060 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2005 | 47 | 0.060 |
Why?
| | Regeneration | 1 | 2006 | 160 | 0.060 |
Why?
| | Deoxyguanosine | 1 | 2004 | 26 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2008 | 776 | 0.060 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 18 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 2008 | 386 | 0.060 |
Why?
| | Supreme Court Decisions | 1 | 2023 | 10 | 0.050 |
Why?
| | Stress Fibers | 1 | 2003 | 16 | 0.050 |
Why?
| | Adherens Junctions | 1 | 2003 | 26 | 0.050 |
Why?
| | Caspase 8 | 1 | 2003 | 43 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2003 | 72 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1268 | 0.050 |
Why?
| | Myosins | 1 | 2003 | 128 | 0.050 |
Why?
| | rho-Associated Kinases | 1 | 2003 | 80 | 0.050 |
Why?
| | Sphingomyelins | 2 | 2015 | 27 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 368 | 0.050 |
Why?
| | Imidazoles | 1 | 2003 | 209 | 0.050 |
Why?
| | Cell Communication | 1 | 2023 | 280 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2201 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 354 | 0.050 |
Why?
| | Epithelium | 1 | 2022 | 297 | 0.050 |
Why?
| | Autophagosomes | 1 | 2021 | 19 | 0.050 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 1879 | 0.050 |
Why?
| | Autoantibodies | 1 | 2008 | 1354 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 39 | 0.050 |
Why?
| | Neurons | 1 | 2008 | 1284 | 0.050 |
Why?
| | Fever | 1 | 2022 | 280 | 0.050 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 99 | 0.040 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2020 | 8 | 0.040 |
Why?
| | Transcription Factor RelA | 1 | 2020 | 83 | 0.040 |
Why?
| | Pyridines | 1 | 2003 | 425 | 0.040 |
Why?
| | Propensity Score | 1 | 2020 | 224 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 91 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 4904 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 696 | 0.040 |
Why?
| | Rats, Inbred WKY | 2 | 2009 | 32 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 744 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2020 | 641 | 0.040 |
Why?
| | Swine | 1 | 2021 | 704 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2022 | 449 | 0.040 |
Why?
| | Cell Lineage | 1 | 2020 | 310 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2020 | 344 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 225 | 0.040 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2018 | 26 | 0.040 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 20 | 0.040 |
Why?
| | Propionates | 1 | 2018 | 34 | 0.040 |
Why?
| | Vital Capacity | 1 | 2018 | 257 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 957 | 0.040 |
Why?
| | Proteomics | 1 | 2023 | 844 | 0.040 |
Why?
| | Protein Stability | 1 | 2018 | 157 | 0.040 |
Why?
| | Nitriles | 1 | 2018 | 152 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2022 | 633 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 253 | 0.040 |
Why?
| | Estrogen Receptor alpha | 1 | 2018 | 121 | 0.040 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1203 | 0.040 |
Why?
| | RNA | 1 | 2023 | 810 | 0.040 |
Why?
| | Sample Size | 1 | 2017 | 112 | 0.040 |
Why?
| | Weight Gain | 1 | 2020 | 451 | 0.030 |
Why?
| | HIV | 1 | 2017 | 208 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 225 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 10498 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 117 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1591 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 1839 | 0.030 |
Why?
| | Antioxidants | 2 | 2013 | 530 | 0.030 |
Why?
| | NF-kappa B | 2 | 2010 | 637 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 12547 | 0.030 |
Why?
| | Physical Endurance | 1 | 2016 | 231 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 342 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2015 | 56 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 334 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2015 | 125 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 53 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 900 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 413 | 0.030 |
Why?
| | Interleukin-23 Subunit p19 | 1 | 2014 | 5 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 94 | 0.030 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.030 |
Why?
| | Indans | 1 | 2014 | 9 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2016 | 196 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 117 | 0.030 |
Why?
| | Oxadiazoles | 1 | 2014 | 32 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 523 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2015 | 292 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 154 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 319 | 0.030 |
Why?
| | Anilides | 1 | 2014 | 67 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1375 | 0.030 |
Why?
| | Thiazoles | 1 | 2014 | 110 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2020 | 729 | 0.030 |
Why?
| | Cricetulus | 1 | 2013 | 97 | 0.030 |
Why?
| | Organophosphonates | 1 | 2014 | 90 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 138 | 0.030 |
Why?
| | Thiophenes | 1 | 2014 | 108 | 0.030 |
Why?
| | Phosphatidylserines | 1 | 2014 | 87 | 0.030 |
Why?
| | Cricetinae | 1 | 2013 | 259 | 0.030 |
Why?
| | Dinitrofluorobenzene | 1 | 2013 | 7 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 2014 | 133 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 559 | 0.030 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2013 | 20 | 0.030 |
Why?
| | Lipid Bilayers | 1 | 2014 | 99 | 0.030 |
Why?
| | Culture Media, Serum-Free | 1 | 2012 | 42 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2015 | 778 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 116 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 139 | 0.030 |
Why?
| | Hydrolases | 1 | 2013 | 51 | 0.030 |
Why?
| | Chemokine CXCL10 | 1 | 2012 | 34 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 164 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 496 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 171 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2020 | 1077 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2015 | 476 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 299 | 0.020 |
Why?
| | Tyrosine | 1 | 2012 | 216 | 0.020 |
Why?
| | Computer Simulation | 1 | 2016 | 880 | 0.020 |
Why?
| | Metaplasia | 1 | 2011 | 54 | 0.020 |
Why?
| | Blood Glucose | 1 | 2020 | 1821 | 0.020 |
Why?
| | Mucus | 1 | 2011 | 54 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 436 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1715 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2082 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 340 | 0.020 |
Why?
| | Th2 Cells | 1 | 2011 | 155 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2009 | 92 | 0.020 |
Why?
| | Rats, Inbred BN | 1 | 2009 | 52 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2009 | 76 | 0.020 |
Why?
| | Spleen | 1 | 2011 | 486 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 116 | 0.020 |
Why?
| | Transplantation, Isogeneic | 1 | 2008 | 17 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1132 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2009 | 201 | 0.020 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 1 | 2008 | 12 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2008 | 79 | 0.020 |
Why?
| | Isoxazoles | 1 | 2008 | 52 | 0.020 |
Why?
| | GTP-Binding Proteins | 1 | 2008 | 141 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6357 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2009 | 697 | 0.020 |
Why?
| | Administration, Oral | 1 | 2009 | 730 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1488 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2009 | 955 | 0.020 |
Why?
| | Postural Balance | 1 | 2008 | 184 | 0.020 |
Why?
| | Pleura | 1 | 2005 | 18 | 0.020 |
Why?
| | Ligation | 1 | 2005 | 76 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 119 | 0.010 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 109 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 772 | 0.010 |
Why?
| | Pulmonary Embolism | 1 | 2005 | 184 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1747 | 0.010 |
Why?
| | Peptides | 1 | 2008 | 849 | 0.010 |
Why?
| | Endopeptidases | 1 | 2003 | 72 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 398 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 9122 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1636 | 0.010 |
Why?
| | Child | 1 | 2017 | 18407 | 0.010 |
Why?
|
|
Petrache's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|